Yeliz Cinar

Title: Yeliz Cinar - Innovator in Peptide Research

Introduction

Yeliz Cinar is a prominent inventor located in Wiesbaden, Germany. With a strong background in scientific research, Cinar has made significant contributions to the field of biotechnology, particularly in peptide research.

Latest Patents

Cinar holds a noteworthy patent titled "Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptides." This innovative patent involves peptides that specifically bind to amino-terminal truncated pEAβ3-42, with the free glutamic acid residue positioned at either 3 or 11 in the form of cyclized pyroglutamate. Four oligopeptides were identified in this breakthrough using mirror image phage display technology.

Career Highlights

Yeliz Cinar is currently affiliated with Forschungszentrum Jülich GmbH, where she actively engages in research and development activities. Her work focuses on advancing the understanding of peptide interactions, which is critical for addressing neurodegenerative diseases.

Collaborations

Throughout her career, Cinar has collaborated with esteemed colleagues, including Dieter Willbold and Susanne Aileen Funke. These partnerships have fostered a rich environment for innovation and have contributed to the advancement of peptide research.

Conclusion

Yeliz Cinar's contributions to the field of biotechnology exemplify the spirit of innovation. Her patent on peptides related to amyloid-beta-peptide highlights her dedication to scientific research and its applications in medicine. As she continues her work at Forschungszentrum Jülich GmbH, her future endeavors are anticipated to yield further advancements in the understanding and treatment of neurodegenerative conditions.